Tags:DataFastHealthTechITLabMachine LearningMedTechPlatformTechnologyTime
Over 300 million people live with a rare genetic disease and for most, the journey from the first symptoms to a diagnosis takes more than 5 years. Even after that, diagnoses are often incorrect, and many people end up not being diagnosed at all. Now, new technology is allowing millions to benefit from genetic testing for diagnosis, while at the same time targeted therapies for previously untreatable disorders are being developed. But the last step in genetic testing – interpreting mutations – remains laborious and costly. It can take a genetic testing lab weeks to interpret data from a single patient. Because of limited understanding of the consequences of mutations, the test results are often inconclusive and leave 70% of people undergoing a genetic test without diagnosis. Our platform leverages a unique combination of machine learning and synthetic biology to characterize mutations at scale and automate the interpretation. By offering it to labs, we enable them to diagnose more people in a fraction of the time.
Likes
3
Location: Germany, Berlin
Member count: 11-50
Total raised: $5.731499M
Founded date: 2018

Investors 5

Funding Rounds 1

DateSeriesAmountInvestorsDeal News
03.02.2022-$5.731499M-tech.eu/20...

Mentions in press and media 6

DateTitleDescriptionCategoryAuthorSource
04.02.2022Roundup: N...Credit: Nostos Genomics Nosto...-Tammy Love...mobihealth...
03.02.2022Berlin-bas...Nostos Genomics, a Berlin-base...funding n...Editorial ...siliconcan...
01.06.2021Genomenon ..."This collaboration stemm...--prweb.com/...
04.12.20207 neue Sta...Jeden Tag entstehen überall in...--deutsche-s...
27.03.2019Meet the E...Entrepreneur First (EF), the c...entreprene...Mike Butch...techcrunch...
-What does ...Berlin-based AI driven genetic...-Megha Paultech.eu/20...